Share Capital (Tables)

6 Months Ended

Jun. 30, 2022

Disclosure of Share Capital [Line Items]

Schedule of Common Stock Outstanding Roll Forward

(b) Issued and Outstanding

A reconciliation of the beginning and ending amounts of the issued and outstanding shares by class is as follows:

	Issued and Outstanding
	Subordinate Voting Shares		Multiple Voting Shares		Super Voting Shares
As at January 1, 2022		201,768,312		38,531		285,031
Issuance of shares under business combinations and investments		204,036		—		—
Distribution of contingent consideration		667,080		—		—
Issuance of shares upon exercise of options and warrants		177,044		—		—
Issuances of shares upon vesting of RSUs		336,005		—		—
Shares issued for settlement of business obligation		80,588		—		—
Exchange of shares		500,000		—		(5,000	)
As at June 30, 2022		203,733,065		38,531		280,031

Share-based Payment Arrangement, Option, Activity

Stock option activity is summarized as follows:

	Number of Shares			Weighted Average Exercise Price C$		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
	(in thousands)
Balance as of December 31, 2021		5,383,275			18.07		3.59	$	48,803
Granted		959,702			23.28		6.45
Exercised		(177,044	)		11.72				1,316
Forfeited		(129,084	)		22.70
Balance as of June 30, 2022		6,036,849			18.99		3.58	$	1,083
Vested		4,515,359			14.44
Exercisable of June 30, 2022		3,065,200			15.17		2.85	$	704

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The Company used the Black-Scholes option pricing model to estimate the fair value of the options granted during the six months ended June 30, 2022 and the year ended December 31, 2021, using the following ranges of assumptions:

	June 30,	December 31,
	2022	2021
Risk-free interest rate	1.18% - 2.87%	0.33% - 1.39%
Expected dividend yield	0%	0%
Expected volatility	60 - 64%	73%
Expected option life	3 – 4.5 years	3 – 3.5 years

Schedule of Stock-Based Compensation Expense

The stock-based compensation expense for the three and six months ended June 30, 2022 and 2021 was as follows:

		Three Months Ended June 30,				Six Months Ended June 30,
		2022		2021		2022		2021
		(in thousands)				(in thousands)
Stock options expense	$	3,775	$	3,709	$	6,982	$	6,338
Restricted Stock Units		3,058		1,963		4,502		3,365
Total Stock Based Compensation Expense	$	6,833	$	5,672	$	11,484	$	9,703

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value and intrinsic value of options exercised for the six months ended June 30, 2022 and 2021:

	Six Months Ended June 30,
	2022		2021
Weighted average grant date fair value (per share) of stock option units granted (C$)		9.21		14.80
Intrinsic value of stock option units exercised, using market price at vest date (US$) (in thousands)	$	1,316	$	10,969

Restricted Stock Units

Disclosure of Share Capital [Line Items]

Non-vested Restricted Stock Shares Activity

The following table summarizes the number of unvested RSU awards as of June 30, 2022 and December 31, 2021 and the changes during the six months ended June 30, 2022:

	Number of Shares	Weighted Average Grant Date Fair Value (C$)
Unvested Shares at December 31, 2021	376,127	20.39
Granted	1,021,221	23.21
Forfeited	(36,684)	23.71
Vested	(336,005)	19.77
Unvested Shares at June 30, 2022	1,024,659	23.35

Summary Of Weighted Average Grant Date Fair Value And Intrinsic Value Of Options Exercised

The following table summarizes the weighted average grant date fair value of RSUs granted and total fair value of RSUs vested for the six months ended June 30, 2022 and 2021:

		Six Months Ended June 30,
		2022			2021
Weighted average grant date fair value (per share) of RSUs granted (C$)			23.21			38.37
Intrinsic value of RSUs vested, using market    price at vest date (US$) (in thousands)	$		5,697	$		9,255